Authors:
JONG MC
GIJBELS MJJ
DAHLMANS VEH
VANGORP PJJ
KOOPMAN SJ
PONEC M
HOFKER MH
HAVEKES LM
Citation: Mc. Jong et al., HYPERLIPIDEMIA AND CUTANEOUS ABNORMALITIES IN TRANSGENIC MICE OVEREXPRESSING HUMAN APOLIPOPROTEIN C1, The Journal of clinical investigation, 101(1), 1998, pp. 145-152
Citation: Cja. Moen et al., TOWARDS IDENTIFICATION OF NEW GENES MODIFYING PLASMA-LIPID LEVELS ANDSUSCEPTIBILITY TO ATHEROSCLEROSIS, Circulation, 98(17), 1998, pp. 2797-2797
Authors:
JONG MC
DAHLMANS VEH
VANGORP PJJ
VANDIJK KW
HOFKER MH
HAVEKES LM
Citation: Mc. Jong et al., THE BINDING OF VERY-LOW-DENSITY LIPOPROTEINS (VLDL) TO THE VLDL RECEPTOR IS INHIBITED BY APOLIPOPROTEIN (APO) C1, Atherosclerosis, 134(1-2), 1997, pp. 358-358
Authors:
JONG MC
DAHLMANS VEH
VANGORP PJJ
BREUER ML
MOL MJTM
VANDERZEE A
FRANTS RR
HOFKER MH
HAVEKES LM
Citation: Mc. Jong et al., BOTH LIPOLYSIS AND HEPATIC-UPTAKE OF VLDL ARE IMPAIRED IN TRANSGENIC MICE COEXPRESSING HUMAN APOLIPOPROTEIN E-ASTERISK-3LEIDEN AND HUMAN APOLIPOPROTEIN C1, Arteriosclerosis, thrombosis, and vascular biology, 16(8), 1996, pp. 934-940
Authors:
JONG MC
DAHLMANS VEH
VANGORP PJJ
VANDIJK KW
BREUER ML
HOFKER MH
HAVEKES LM
Citation: Mc. Jong et al., IN THE ABSENCE OF THE LOW-DENSITY-LIPOPROTEIN RECEPTOR, HUMAN APOLIPOPROTEIN C1 OVEREXPRESSION IN TRANSGENIC MICE INHIBITS THE HEPATIC-UPTAKE OF VERY-LOW-DENSITY LIPOPROTEINS VIA A RECEPTOR-ASSOCIATED PROTEIN-SENSITIVE PATHWAY, The Journal of clinical investigation, 98(10), 1996, pp. 2259-2267
Authors:
VANVLIJMEN BJM
VANDIJK KW
VANTHOF HB
VANGORP PJJ
VANDERZEE A
VANDERBOOM H
BREUER ML
HOFKER MH
HAVEKES LM
Citation: Bjm. Vanvlijmen et al., IN THE ABSENCE OF ENDOGENOUS MOUSE APOLIPOPROTEIN-E, APOLIPOPROTEIN E-ASTERISK-2(ARG-158-]CYS) TRANSGENIC MICE DEVELOP MORE SEVERE HYPERLIPOPROTEINEMIA THAN APOLIPOPROTEIN E-ASTERISK-3-LEIDEN TRANSGENIC MICE, The Journal of biological chemistry, 271(48), 1996, pp. 30595-30602
Authors:
JONG MC
DAHLMANS VEH
VANGORP PJJ
VANDIJK KW
HOFKER MH
HAVEKES LM
Citation: Mc. Jong et al., OVEREXPRESSION OF HUMAN APOC1 IN TRANSGENIC MICE INHIBITS THE HEPATIC-UPTAKE OF VLDL VIA A RECEPTOR-ASSOCIATED PROTEIN (RAP)-SENSITIVE PATHWAY, Circulation, 94(8), 1996, pp. 4077-4077